2402264
|
|
|
FR
|
- COVID-19
- SARS-CoV-2 test
- Vaccination failure
|
|
|
2021-10-29
|
278
|
2402265
|
|
|
FR
|
- COVID-19
- SARS-CoV-2 test
- Vaccination failure
|
|
|
2022-01-16
|
192
|
2402266
|
|
|
FR
|
- Activated partial thromboplastin time
- Alanine aminotransferase
- Amylase
- Angiocardiogram
- Aspartate aminotransferase
- Base excess
- Bilirubin conjugated
- Blood alkaline phosphatase
- Blood bicarbonate
- Blood bilirubin
- Blood chloride
- Blood cholesterol
- Blood creatine phosphokinase
- Blood creatinine
- Blood glucose
- Blood lactate dehydrogenase
- Blood lactic acid
- Blood pH
- Blood potassium
- Blood sodium
- Blood triglycerides
- Blood urea
- C-reactive protein
- Carbon dioxide
- Chest pain
- Computerised tomogram thorax
- Echocardiogram
- Electrocardiogram
- Eosinophil count
- Gamma-glutamyltransferase
- Glomerular filtration rate
- Haematocrit
- Haemoglobin
- High density lipoprotein
- Hyperhidrosis
- International normalised ratio
- Laboratory test
- Lipase
- Low density lipoprotein
- Lymphocyte count
- Mean cell haemoglobin
- Mean cell haemoglobin concentration
- Mean cell volume
- Mean platelet volume
- Monocyte count
- Myocardial infarction
- N-terminal prohormone brain natriuretic peptide
- Neutrophil count
- Neutrophil percentage
- PCO2
- PO2
- Platelet count
- Procalcitonin
- Prothrombin time
- Red blood cell count
- Red cell distribution width
- SARS-CoV-2 test
- Troponin I
- White blood cell count
|
Hospitalized Life Threatening Recovered
|
FD8274
|
2021-07-06
|
332
|
2402267
|
|
|
FR
|
- Cerebral haemorrhage
- Cerebral thrombosis
- Cerebrospinal fluid retention
|
Hospitalized Life Threatening Permanent Disability
|
|
|
|
2402268
|
|
|
FR
|
- COVID-19
- Fatigue
- SARS-CoV-2 test
- Vaccination failure
|
Recovered
|
FD8274
|
2021-07-06
|
134
|
2402269
|
|
|
FR
|
- Antibody test
- Magnetic resonance imaging
- Myelin oligodendrocyte glycoprotein antibody-associated disease
- Myelitis transverse
- Optic neuritis
- Visual acuity tests
|
Recovered
|
|
|
|
2402270
|
32
|
|
FR
|
- Drug ineffective
- Suspected COVID-19
|
|
1F1013A
|
2022-01-17
|
|
2402271
|
|
|
FR
|
- Asthenia
- Respiratory distress
|
|
|
|
|
2402272
|
|
|
FR
|
- Investigation
- Rhinitis allergic
- Vocal cord polyp
|
|
|
2021-12-22
|
14
|
2402273
|
|
|
FR
|
- Chest X-ray
- Chest pain
- Electrocardiogram
- Headache
- Myocardial necrosis marker
- Sinus tachycardia
|
|
|
2022-07-06
|
4
|
|
2402275
|
|
|
FR
|
- Inappropriate schedule of product administration
- Rash erythematous
|
Hospitalized
|
|
2022-01-14
|
0
|
2402657
|
|
|
FR
|
- Dry skin
- Inappropriate schedule of product administration
- Rash
- Rash erythematous
|
|
|
2021-04-15
|
0
|
2359462
|
74
|
|
PA
|
- Breast disorder female
- Laboratory test
|
Life Threatening
|
FK9894
|
2022-04-05
|
21
|
2365963
|
7
|
|
CA
|
|
Recovered
|
FL0094
|
2022-06-24
|
|
2366947
|
17
|
|
NY
|
|
Recovered
|
FM0173
|
2022-06-27
|
5
|
2367346
|
8
|
|
CT
|
- Dyspnoea
- Hyperhidrosis
- Hypoaesthesia
- Mobility decreased
- Muscle spasms
- Nausea
- Pallor
|
Recovered
|
FL8095
|
2022-07-06
|
1
|
2370200
|
96
|
|
|
- Asthenia
- Dizziness
- Fall
- Hypersomnia
- Immunisation reaction
- Interchange of vaccine products
|
|
|
2021-12-02
|
3
|
2370206
|
88
|
|
|
- Chills
- Hyperhidrosis
- Lethargy
- Pneumonia
- Pyrexia
|
|
FM7553
|
|
|
2370207
|
65
|
|
|
- Incomplete course of vaccination
|
|
FK9729
|
2022-02-07
|
0
|
2370210
|
51
|
|
|
|
|
|
|
|
2370214
|
79
|
|
|
- Immunisation reaction
- Urticaria
|
|
|
2021-03-24
|
344
|
2370226
|
66
|
|
|
|
|
|
|
|
2370233
|
52
|
|
|
- Chest pain
- Fibrin D dimer
- Muscle spasms
- Myalgia
- Tinnitus
- Urticaria
|
|
NOTPROVIDED
|
|
|
2370241
|
26
|
|
|
- Angioedema
- Immunisation reaction
- Urticaria
|
|
|
2021-03-16
|
409
|
2370243
|
74
|
|
|
- Dizziness
- Dysstasia
- Fatigue
- Gait inability
- Headache
- Immunisation reaction
- Pyrexia
- Vision blurred
|
|
|
|
|
2370334
|
56
|
|
|
- Fatigue
- Headache
- Injection site pain
- Myalgia
- Pyrexia
|
|
FP7135
|
2022-06-13
|
1
|
2373151
|
8
|
|
WI
|
- Erythema
- Lip swelling
- Rash
- Skin lesion
- Swelling of eyelid
|
Recovered
|
FK5127
|
2021-12-03
|
133
|
2373441
|
44
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EJ1686
|
2020-12-18
|
230
|
2373444
|
32
|
|
|
- Abdominal discomfort
- Chills
- Pain
- Pyrexia
|
Recovered
|
ER8736
|
2021-09-08
|
1
|
2373446
|
27
|
|
|
- Dyspnoea
- Dyspnoea exertional
- Headache
- Myalgia
- Oxygen saturation decreased
|
|
FC3182
|
2021-09-05
|
0
|
2373448
|
35
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EJ1686
|
2020-12-17
|
234
|
2373453
|
42
|
|
|
- Dizziness
- Headache
- Hot flush
- Pyrexia
|
Recovered
|
ER8734
|
2021-09-10
|
0
|
2373459
|
54
|
|
|
|
Recovered
|
EW0161
|
2021-09-07
|
0
|
2373462
|
70
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EW0153
|
2021-08-26
|
|
2373465
|
60
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EJ1686
|
2020-12-21
|
226
|
2373471
|
36
|
|
|
|
Recovered
|
EW0161
|
2021-08-16
|
23
|
2373478
|
23
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
|
|
2021-01-15
|
234
|
2373479
|
37
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EK4176
|
2021-01-20
|
235
|
2373493
|
64
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EL3247
|
2021-01-08
|
216
|
2373500
|
50
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EN6203
|
2021-02-02
|
190
|
2373502
|
52
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EL9262
|
2021-01-15
|
208
|
2373505
|
32
|
|
|
- Headache
- Injection site pain
|
Recovered
|
EW0161
|
2021-09-17
|
1
|
2373508
|
40
|
|
|
- COVID-19
- SARS-CoV-2 test positive
|
Recovered
|
EN5318
|
2021-01-04
|
218
|
2373512
|
69
|
|
|
|
Recovered
|
FE3592
|
2021-09-09
|
0
|
2373514
|
47
|
|
|
- Dizziness
- Headache
- Injection site pain
- Nausea
- Vomiting
|
Recovered
|
EW0153
|
2021-09-20
|
1
|
2373525
|
7
|
|
CA
|
- Inappropriate schedule of product administration
|
Recovered
|
FL8094
|
2022-04-05
|
|
2373526
|
68
|
|
NJ
|
- Arthralgia
- Dermatitis
- Insomnia
- Visual impairment
|
|
|
2022-07-13
|
0
|
2374449
|
53
|
|
|
- Fatigue
- Headache
- Injection site pain
- Myalgia
|
|
EH9899
|
2020-12-18
|
0
|
2376073
|
16
|
|
ID
|
- Incorrect dose administered
- Product administered to patient of inappropriate age
|
|
|
2022-06-06
|
|
2376139
|
|
|
NY
|
|
|
|
|
|